Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

A more efficient method to generate integration-free human iPS cells

Nature Methods volume 8, pages 409–412 (2011)Cite this article

Subjects

Abstract

We report a simple method, using p53 suppression and nontransforming L-Myc, to generate human induced pluripotent stem cells (iPSCs) with episomal plasmid vectors. We generated human iPSCs from multiple donors, including two putative human leukocyte antigen (HLA)-homozygous donors who match ∼20% of the Japanese population at major HLA loci; most iPSCs are integrated transgene-free. This method may provide iPSCs suitable for autologous and allologous stem-cell therapy in the future.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Establishment of human iPSCs.
Figure 2: Characterization of pla-iPSC clones.
Figure 3: Estimated coverage of the Japanese population by HLA homozygous donors.

Similar content being viewed by others

References

  1. Okita, K., Ichisaka, T. & Yamanaka, S. Nature 448, 313–317 (2007).

    Article  CAS  Google Scholar 

  2. Zhou, W. & Freed, C.R. Stem Cells 27, 2667–2674 (2009).

    Article  CAS  Google Scholar 

  3. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Proc. Jpn. Acad. B 85, 348–362 (2009).

    Article  CAS  Google Scholar 

  4. Woltjen, K. et al. Nature 458, 766–770 (2009).

    Article  CAS  Google Scholar 

  5. Jia, F. et al. Nat. Methods 7, 197–199 (2010).

    Article  CAS  Google Scholar 

  6. Yu, J. et al. Science 324, 797–801 (2009).

    Article  CAS  Google Scholar 

  7. Kim, D. et al. Cell Stem Cell 4, 472–476 (2009).

    Article  CAS  Google Scholar 

  8. Warren, L. et al. Cell Stem Cell 7, 618–630 (2010).

    Article  CAS  Google Scholar 

  9. Hong, H. et al. Nature 460, 1132–1135 (2009).

    Article  CAS  Google Scholar 

  10. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T. & Yamanaka, S. Proc. Natl. Acad. Sci. USA 107, 14152–14157 (2010).

    Article  CAS  Google Scholar 

  11. Tamaoki, N. et al. J. Dent. Res. 89, 773–778 (2010).

    Article  CAS  Google Scholar 

  12. Nakatsuji, N., Nakajima, F. & Tokunaga, K. Nat. Biotechnol. 26, 739–740 (2008).

    Article  CAS  Google Scholar 

  13. Tsuji, O. et al. Proc. Natl. Acad. Sci. USA 107, 12704–12709 (2010).

    Article  CAS  Google Scholar 

  14. Takemoto, S.K., Terasaki, P.I., Gjertson, D.W. & Cecka, J.M. N. Engl. J. Med. 343, 1078–1084 (2000).

    Article  CAS  Google Scholar 

  15. Aydingoz, S.E. et al. Hum. Immunol. 68, 491–499 (2007).

    Article  CAS  Google Scholar 

  16. McMahon, A.P. & Bradley, A. Cell 62, 1073–1085 (1990).

    Article  CAS  Google Scholar 

  17. Takahashi, K. et al. Cell 131, 861–872 (2007).

    Article  CAS  Google Scholar 

  18. Niwa, H., Yamamura, K. & Miyazaki, J. Gene 108, 193–199 (1991).

    Article  CAS  Google Scholar 

  19. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Science 322, 949–953 (2008).

    Article  CAS  Google Scholar 

  20. Morizane, A., Doi, D., Kikuchi, T., Nishimura, K. & Takahashi, J. J. Neurosci. Res. 89, 117–126 (2010).

    Article  Google Scholar 

  21. Kawasaki, H. et al. Proc. Natl. Acad. Sci. USA 99, 1580–1585 (2002).

    Article  CAS  Google Scholar 

  22. Osakada, F. et al. J. Cell Sci. 122, 3169–3179 (2009).

    Article  CAS  Google Scholar 

  23. Itoh, Y. et al. Immunogenetics 57, 717–729 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank K. Takahashi, T. Aoi and Y. Yoshida for scientific discussion; M. Narita, T. Ichisaka, M. Ohuchi, M. Nishikawa and N. Takizawa for technical assistance; R. Kato, E. Nishikawa, S. Takeshima, Y. Ohtsu and H. Hasaba for administrative assistance; and H. Niwa (RIKEN) and J. Miyazaki (Osaka University) for the CAG promoter. This study was supported in part by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation, a grant from the Leading Project of Ministry of Education, Culture, Sports, Science and Technology (MEXT), a grant from Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science and MEXT (to S.Y.) and Senri Life Science Foundation (to K.O.). H.H. is supported by a Japanese government (MEXT) scholarship.

Author information

Authors and Affiliations

  1. Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan

    Keisuke Okita, Yasuko Matsumura, Yoshiko Sato, Aki Okada, Asuka Morizane, Hyenjong Hong, Masato Nakagawa, Koji Tanabe, Masayo Takahashi, Jun Takahashi & Shinya Yamanaka

  2. Department of Biological Repair, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan

    Asuka Morizane & Jun Takahashi

  3. Laboratory for Retinal Regeneration, Center for Developmental Biology, RIKEN, Kobe, Japan

    Satoshi Okamoto & Masayo Takahashi

  4. Department of Tissue and Organ Development, Gifu University Graduate School of Medicine, Gifu, Japan

    Ken-ichi Tezuka & Takahiro Kunisada

  5. Department of Oral and Maxillofacial Science, Gifu University Graduate School of Medicine, Gifu, Japan

    Toshiyuki Shibata

  6. Human Leukocyte Antigen (HLA) Laboratory, Kyoto, Japan

    Hiroh Saji

  7. Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan

    Shinya Yamanaka

  8. Yamanaka Induced Pluripotent Stem Cell Project, Japan Science and Technology Agency, Kawaguchi, Japan

    Shinya Yamanaka

  9. Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA

    Shinya Yamanaka

Authors
  1. Keisuke Okita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuko Matsumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiko Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aki Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Asuka Morizane
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Satoshi Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hyenjong Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masato Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Koji Tanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ken-ichi Tezuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Toshiyuki Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takahiro Kunisada
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Masayo Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jun Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Hiroh Saji
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Shinya Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.O. and S.Y. conceived the project and wrote the manuscript. K.O. constructed the vectors with H.H., M.N. and K. Tanabe, and conducted most of the experiments with Y.M., Y. S. and A.O. A.M. and J.T. carried out the differentiation experiment into dopaminergic neurons. S.O. and M.T. performed differentiation into retinal pigment epithelial cells. K. Tezuka., T.S. and T.K. established dental pulp cell lines. H.S. performed HLA haplotyping in Japanese population and supervised HLA analysis.

Corresponding authors

Correspondence to Keisuke Okita or Shinya Yamanaka.

Ethics declarations

Competing interests

K.O., M.N. and S.Y. are filing a patent application to Japan, US and EU based on the results reported in this paper (PCT/JP2010/063733). S.Y. is a member of Scientific Advisory Board for iPS Academia Japan Inc. and iPierian Inc., which manage the patents.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–9 and Supplementary Tables 1–7 and 9, 10 (PDF 1911 kb)

Supplementary Table 8

Haplotype frequency for HLA-A, HLA-B and HLA-DRB1 loci in Japanese population. (XLS 395 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okita, K., Matsumura, Y., Sato, Y. et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409–412 (2011). https://doi.org/10.1038/nmeth.1591

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.1591

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing